Price (delayed)
$39.14
Market cap
$1.8B
P/E Ratio
111.83
Dividend/share
N/A
EPS
$0.35
Enterprise value
$2.46B
Pacira BioSciences, Inc.is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. The company's long-acting local
There are no recent dividends present for PCRX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.